LFCR
$4.36
Lifecore Biomedical, Inc., together with its subsidiaries, operates as an integrated contract development and manufacturing organization that serves customers in the United States, Belgium, the Netherlands, and internationally.
Intraday
Recent News
Lifecore Biomedical Inc (LFCR) Q4 2025 Earnings Call Highlights: Strong Revenue Growth and ...
Lifecore Biomedical Inc (LFCR) reports a 10% revenue increase in Q4 2025 and outlines strategic initiatives to drive future growth despite anticipated challenges.
Lifecore Biomedical Q4 Earnings Call Highlights
Lifecore Biomedical (NASDAQ:LFCR) used its fiscal fourth-quarter earnings call to highlight revenue growth, improving margins, and continued cost reductions during its transition to a calendar-year reporting cycle. Management also discussed progress on commercial milestones tied to its largest custo
What Contributes to Lifecore Biomedical’s (LFCR) Distinct Competitive Advantage?
Laughing Water Capital, an investment management company, released its fourth-quarter 2025 investor letter. In the quarter, Laughing Water Capital returned ~6.8%, bringing the full-year returns to ~3.9% net of fees and expenses. In comparison, the SP500TR and R2000 returned approximately 2.7% and 2.2%, respectively, in the quarter, and finished the year up by 17.9% and […]
One Lifecore Biomedical Insider Raised Their Stake In The Previous Year
From what we can see, insiders were net buyers in Lifecore Biomedical, Inc.'s ( NASDAQ:LFCR ) during the past 12...
How Recent Developments Are Rewriting the Story for Lifecore Biomedical
Lifecore Biomedical's stock narrative remains in focus as the consensus analyst price target stays unchanged at $8.75. This reflects steady expectations despite evolving market conditions. Shifts in revenue growth projections and a modest uptick in discount rate signal recalibration of both optimism and caution among analysts. Stay tuned to find out how to follow these developments and keep up with important updates to Lifecore's evolving story. Stay updated as the Fair Value for Lifecore...